Product Information
SYNJARDY XR 5-1,000 MG TABLET is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $5.6094 per EA under NDC 00597029059. Its NADAC has been published 423 times since May 23, 2018.
Strength
5; 1000 mg/1; mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597029059
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA208658On Market Since
12/10/2016
Pharmacological Classes
Price Statistics
The NADAC for SYNJARDY XR 5-1,000 MG TABLET has been published 423 times since May 23, 2018, and over the history we have for it it has declined 24.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.6094 per EA |
|---|---|
| All-time high | $10.1096 (Jun 11, 2025) |
| All-time low | $5.6059 (May 20, 2026) |
| 52-week high | $10.0975 |
| 52-week low | $5.6059 |
| Median price | $8.7687 |
| Average price | $8.7299 |
| Largest weekly change | -44.4% (Jan 7, 2026) |
| Weeks tracked | 423 |
| Tracking since | May 23, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SYNJARDY XR 5-1,000 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SYNJARDY XR 5-1,000 MG TABLET, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $5.6094 per EA (NDC 00597029059), effective Jun 24, 2026.
How has the price of SYNJARDY XR 5-1,000 MG TABLET changed over time?
Over the history we have for it, the NADAC for SYNJARDY XR 5-1,000 MG TABLET has declined 24.3%. It has been tracked across 423 weekly CMS publications since May 23, 2018.
What are the highest and lowest recorded NADAC prices for SYNJARDY XR 5-1,000 MG TABLET?
Since May 23, 2018, the NADAC for SYNJARDY XR 5-1,000 MG TABLET has ranged from a low of $5.6059 (May 20, 2026) to a high of $10.1096 (Jun 11, 2025), with a median of $8.7687 per EA.
Are there cheaper alternatives to SYNJARDY XR 5-1,000 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as SYNJARDY XR 5-1,000 MG TABLET, but none are currently priced below it.
Who manufactures SYNJARDY XR 5-1,000 MG TABLET?
SYNJARDY XR 5-1,000 MG TABLET (NDC 00597029059) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification